Industrial FDA Form 483 Observations and Warning Letters to Pharmaceutical Companies: A Ten-Year Review and Case-Study Analysis of Regulatory Compliance Trends (2016–2026)

By: Dr.Surendra Pardhi, Suresh Singh Rajput, Dr. Atul Bisen, Yogesh Dewahe, Dr. Vaibhav Solanki